title: Vitamin D and human health: lessons from vitamin D receptor null mice.
abstract: The vitamin D endocrine system is essential for calcium and bone homeostasis. The precise mode of action and the full spectrum of activities of the vitamin D hormone, 1,25-dihydroxyvitamin D [1,25-(OH)(2)D], can now be better evaluated by critical analysis of mice with engineered deletion of the vitamin D receptor (VDR). Absence of a functional VDR or the key activating enzyme, 25-OHD-1alpha-hydroxylase (CYP27B1), in mice creates a bone and growth plate phenotype that mimics humans with the same congenital disease or severe vitamin D deficiency. The intestine is the key target for the VDR because high calcium intake, or selective VDR rescue in the intestine, restores a normal bone and growth plate phenotype. The VDR is nearly ubiquitously expressed, and almost all cells respond to 1,25-(OH)(2)D exposure; about 3% of the mouse or human genome is regulated, directly and/or indirectly, by the vitamin D endocrine system, suggesting a more widespread function. VDR-deficient mice, but not vitamin D- or 1alpha-hydroxylase-deficient mice, and man develop total alopecia, indicating that the function of the VDR and its ligand is not fully overlapping. The immune system of VDR- or vitamin D-deficient mice is grossly normal but shows increased sensitivity to autoimmune diseases such as inflammatory bowel disease or type 1 diabetes after exposure to predisposing factors. VDR-deficient mice do not have a spontaneous increase in cancer but are more prone to oncogene- or chemocarcinogen-induced tumors. They also develop high renin hypertension, cardiac hypertrophy, and increased thrombogenicity. Vitamin D deficiency in humans is associated with increased prevalence of diseases, as predicted by the VDR null phenotype. Prospective vitamin D supplementation studies with multiple noncalcemic endpoints are needed to define the benefits of an optimal vitamin D status.
authors.affiliation: Katholieke Universiteit Leuven, Laboratory of Experimental Medicine and Endocrinology, Herestraat 49, O&N 1 bus 902, 3000 Leuven, Belgium. Roger.Bouillon@med.kuleuven.be
authors.forename: Roger
authors.initials: R
authors.lastname: Bouillon
authors.forename: Geert
authors.initials: G
authors.lastname: Carmeliet
authors.forename: Lieve
authors.initials: L
authors.lastname: Verlinden
authors.forename: Evelyne
authors.initials: E
authors.lastname: van Etten
authors.forename: Annemieke
authors.initials: A
authors.lastname: Verstuyf
authors.forename: Hilary F
authors.initials: HF
authors.lastname: Luderer
authors.forename: Liesbet
authors.initials: L
authors.lastname: Lieben
authors.forename: Chantal
authors.initials: C
authors.lastname: Mathieu
authors.forename: Marie
authors.initials: M
authors.lastname: Demay
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004703:Endocrine System / Q000502:physiology; D004700:Endocrine System Diseases / Q000503:physiopathology*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D018167:Receptors, Calcitriol / Q000235:genetics / Q000502:physiology*; D014807:Vitamin D / Q000502:physiology*
chemical_list: D018167:Receptors, Calcitriol; D014807:Vitamin D